about
iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles.A quantitative comparison of BOLD fMRI responses to noxious and innocuous stimuli in the human spinal cord.Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study.Topiramate in the prevention of pediatric migraine: literature review.Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV.Definitive childlessness in women with multiple sclerosis: a multicenter study.Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis.Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome.Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.Letter to Editor: Carpal tunnel syndrome due to an atypical deep soft tissue leiomyoma: the risk of misdiagnosis and mismanagement.Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient.Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate.Multiple attack study on the available triptans in Italy versus placebo.Left thalamomegaly in a patient with partial epilepsy.Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis.Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study.Semiautomated segmentation of the human spine based on echoplanar images.Acute necrotizing encephalopathy: a relapsing case in a European adult.Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?Topiramate and triptans revert chronic migraine with medication overuse to episodic migraineFalse positive absent somatosensory evoked potentials in cardiac arrest with therapeutic hypothermiaSevere anemia in a patient with multiple sclerosis treated with natalizumabCerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosisPlasma neurofilaments correlate with disability in progressive multiple sclerosis patients
P50
Q30368046-1AF8D010-8BBC-46E5-B83F-AC4645F3E3FAQ33526105-849DB1AB-7E1F-41D8-8AAB-9214B9E57498Q33545516-EAD90558-8E8C-4C65-86C5-05EDC80CF797Q36662439-53393CA8-B85A-492C-8E7E-5EE390F4717EQ38226374-C767E14A-0B23-4681-9EE6-14D7CC76EBBAQ38679960-688D1CF1-6AD1-45B6-9C70-24F300A33E99Q39101567-1AAE0C3A-377A-4AFF-8B71-6597ECD4FA27Q40385575-38BC12F0-7058-49A2-B82A-26BB84C95544Q40461057-337DA086-EEDF-4102-B23B-23C7BE9DDD5CQ40729676-95971CE4-D914-4463-98D3-09A479D5F36FQ41669067-3F4F6AC6-D893-4B48-82AC-746E1C70C355Q43092049-055B9B3C-6BE0-4DA9-9D42-127238AD3F11Q43652371-6EEF06A1-0970-4598-A4D0-26A2221F5A3FQ43834053-F0F18C64-B6FE-4F9A-9156-03A3C3AEE226Q45205475-973C569D-D14B-46B4-A10D-C77CC2797650Q45986094-8B5C47C8-342C-47F3-9C9F-76FE2102923AQ46548647-3EC64CE4-A30B-4058-B37F-B0DA913F568FQ46838777-6DBC2942-2CCE-4385-9864-42B309DB3DCCQ46913620-AB7DB595-99B6-4E04-8529-483A5066D336Q48162212-06CFBA34-D748-43D4-A462-7670122C0745Q48314755-38C963FD-E41D-4698-A832-0E8108F052FDQ51012384-114C55E5-4D34-44ED-BC45-8345C6DDC0C4Q51166739-2A159409-C964-43A7-B718-4142CEA2E311Q51484236-AA237221-E08E-4CD6-B59F-C1D47554421CQ53464591-5E7231B7-8CC1-4B24-881F-7B498AA715D5Q61928259-89EBA4FD-A18B-4F96-8E23-C5A8F762BF49Q80230400-A764315B-3870-4DC6-B631-F7DFDA97F84CQ85235991-3AEFE0F0-3DC5-4EC1-B532-329E7857305BQ88109350-87B6F3AA-8524-4525-A545-03C0D68429EAQ91225386-F9EBC2D5-67FA-4CB8-8AE9-F53F2CD53FC3Q92217863-E6ED2549-DF26-4B5D-B39B-3B455AFA0EFE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Diana Ferraro
@ast
Diana Ferraro
@en
Diana Ferraro
@es
Diana Ferraro
@nl
Diana Ferraro
@sl
type
label
Diana Ferraro
@ast
Diana Ferraro
@en
Diana Ferraro
@es
Diana Ferraro
@nl
Diana Ferraro
@sl
prefLabel
Diana Ferraro
@ast
Diana Ferraro
@en
Diana Ferraro
@es
Diana Ferraro
@nl
Diana Ferraro
@sl
P106
P1153
7005670751
P21
P31
P496
0000-0003-4818-3806